Literature DB >> 8811641

Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection.

T T Nguyen1, A Sedghi-Vaziri, L B Wilkes, T Mondala, P J Pockros, K L Lindsay, J G McHutchison.   

Abstract

A recently available assay to quantify serum viral load in hepatitis C virus (HCV) infection has been used to evaluate the effects of anti-viral therapies. However, variability in HCV RNA levels in untreated patients with HCV infection has not yet been established. We therefore prospectively measured the biological fluctuations of HCV RNA in sera from untreated patients with chronic HCV infection. Sera were collected from seven patients at 8 am and 4 pm on the same day to assess the effect of diurnal variation, daily for 5 days in a further 10 patients, biweekly for 6 weeks in nine patients and monthly for 3 months in 11 patients. All patients had biopsy-proven chronic liver disease with elevated alanine aminotransferase (ALT) values and had not received anti-viral treatment. HCV RNA was measured blinded, in duplicate, using the quantitative branched (bDNA) amplification assay (Quantiplex HCV RNA, Chiron Co. Emeryville, CA) 36 of the 37 patients studied had measurable HCV RNA throughout the study. There was no significant correlation between HCV RNA levels and ALT values or histological activity. HCV RNA levels did not appear to vary significantly within any of the groups studied and there did not appear to be a change associated with diurnal variation. All individual patients demonstrated less than a threefold fluctuation in HCV RNA throughout the study period. Hence HCV RNA levels remain relatively stable in untreated individuals with chronic HCV infection. Changes of a magnitude of threefold (0.5 log) or greater in HCV RNA levels were not observed in untreated patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811641     DOI: 10.1111/j.1365-2893.1996.tb00084.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  23 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 2.  Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.

Authors:  C L Cooper; Curtis L Cooper; Paul MacPherson; William Cameron
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

Review 3.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

4.  Understanding the nature of early HCV RNA blips and the use of mathematical modeling of viral kinetics during IFN-based therapy.

Authors:  Jeremie Guedj; Harel Dahari; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-30       Impact factor: 11.205

5.  Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection.

Authors:  F Maggi; M Pistello; M Vatteroni; S Presciuttini; S Marchi; P Isola; C Fornai; S Fagnani; E Andreoli; G Antonelli; M Bendinelli
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 6.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

7.  Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.

Authors:  Harel Dahari; Jeremie Guedj; Alan S Perelson; Thomas J Layden
Journal:  Curr Hepat Rep       Date:  2011-07-02

8.  Novel symmetrical phenylenediamines as potential anti-hepatitis C virus agents.

Authors:  Marcella Bassetto; Salvatore Ferla; Pieter Leyssen; Johan Neyts; Mark M Yerukhimovich; David N Frick; Rachel O'Donnell; Andrea Brancale
Journal:  Antivir Chem Chemother       Date:  2016-11-04

9.  Hepatitis C Viral Kinetics in Special Populations.

Authors:  Harel Dahari; Jennifer E Layden-Almer; Alan S Perelson; Thomas J Layden
Journal:  Curr Hepat Rep       Date:  2008

10.  Assessment of spontaneous fluctuations of viral load in untreated patients with chronic hepatitis C by two standardized quantitation methods: branched DNA and Amplicor Monitor.

Authors:  P Halfon; M Bourlière; G Halimi; H Khiri; P Bertezene; I Portal; D Botta-Fridlund; A P Gauthier; M Jullien; J M Feryn; V Gerolami; G Cartouzou
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.